Cover Image

The Safety, Tolerability, and Pharmacokinetics of Active Ingredients From Hydroxysafflor Yellow A in Healthy Chinese Volunteers

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Xiuli Zhao, Shanye Gu, Xia wang, Yefeng Cai, Ziyi Zhou
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Clinical Pharmacology in Drug Development
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Safety, Tolerability, and Pharmacokinetics of Voriconazole for Injection in Two Preparations in Chinese Healthy Adult Volunteers
by: Jin Yu, et al.
Published: (2024)

Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Voriconazole Tablets in Healthy Chinese Volunteers
by: Pan Luo, et al.
Published: (2026)

Pharmacokinetics, Safety, and Tolerability of Cedirogant in Healthy Japanese and Chinese Adults
by: Mohamed‐Eslam F Mohamed, et al.
Published: (2024)

Pharmacokinetics and Bioequivalence of Vardenafil Hydrochloride in Healthy Chinese Volunteers
by: Sheng He, et al.
Published: (2024)

Safety, Tolerability, and Pharmacokinetic Profile of the Low‐Impact Ampakine CX1739 in Young Healthy Volunteers
by: Daniel P. Radin, et al.
Published: (2024)

Bioequivalence and Pharmacokinetic Evaluation of Regorafenib Tablets in Healthy Chinese Volunteers
by: Zhaoyu Wang, et al.
Published: (2024)

Comparability of Elezanumab Safety, Tolerability, and Pharmacokinetics in Healthy Japanese, Chinese, and White Participants
by: Hari V. Kalluri, et al.
Published: (2024)

Safety, Tolerability, and Pharmacokinetics of Galcanezumab, an Anti‐CGRP Antibody, in Healthy Chinese Participants
by: Jingjing Wang, et al.
Published: (2025)

Pharmacokinetics and Bioequivalence Evaluation of Trazodone Hydrochloride Sustained‐Release Tablets in Healthy Chinese Volunteers
by: Jingyan Wang, et al.
Published: (2024)

Bioequivalence and Pharmacokinetic Evaluation of Gliclazide Modified‐Release Tablets in Healthy Chinese Volunteers
by: Kejia Fu, et al.
Published: (2026)

Intravenous Ganaxolone: Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability in Healthy Adults
by: Maciej Gasior, et al.
Published: (2024)

Bioequivalence of Meloxicam Nanocrystal Injection in Healthy Chinese Volunteers
by: Shengling Hu, et al.
Published: (2024)

Safety, Tolerability, and Pharmacokinetics of Single‐ and Multiple‐Ascending Doses of Sunobinop in Healthy Participants
by: Alessandra Cipriano, et al.
Published: (2024)

Safety, Tolerability, and Pharmacokinetics of Donanemab in Healthy Chinese Participants: A Phase 1, Randomized, Double‐Blind, Placebo‐Controlled Study
by: Junyu Xu, et al.
Published: (2025)

Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Oral Formulations of Calcium Dobesilate Capsules in Healthy Chinese Volunteers Under Fasting and Fed Conditions
by: Yanrong Wang, et al.
Published: (2024)

Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan and Amlodipine Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions
by: Yu‐Ying Xu, et al.
Published: (2025)

Bioequivalence and Pharmacokinetics of Ibuprofen Extended‐Release Capsules in Healthy Chinese Volunteers Under Fasting and Postprandial Conditions
by: Mingqi Chen, et al.
Published: (2025)

Pharmacokinetics, Bioequivalence, and Safety of Levothyroxine Sodium Tablets in Healthy Chinese Subjects
by: Juan Jin, et al.
Published: (2025)

Pharmacokinetics, Bioequivalence, and Safety of Bromocriptine Mesylate Tablets in Healthy Chinese Subjects
by: Huan Song, et al.
Published: (2025)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Neonatal Fc Receptor Inhibitor Rozanolixizumab: An Ethnic Sensitivity Study in Healthy Japanese, Chinese, and White Participants
by: Assem el Baghdady, et al.
Published: (2024)

Comparative Pharmacokinetics and Bioequivalence of 2 Formulations of Bosentan Dispersible Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions
by: Zhaoming Huang, et al.
Published: (2025)

Comparative Bioequivalence and Safety Evaluation of Ibuprofen/Phenylephrine Hydrochloride Fixed‐Dose Combination Tablets in Healthy Chinese Volunteers
by: Menghan Ye, et al.
Published: (2025)

A Phase 1 Bioequivalence Study to Assess the Pharmacokinetics, Safety and Tolerability of Guselkumab After a Single‐Dose Administration via Two Subcutaneous Injection Devices in Healthy Volunteers
by: Angela Jeong, et al.
Published: (2026)

Safety and Pharmacokinetics of Single‐Dose Mirikizumab in Chinese Healthy Participants: Results From a Phase 1 Study
by: Junyu Xu, et al.
Published: (2024)

Effect of High‐Fat Food on the Pharmacokinetics and Safety of Amlodipine/Benazepril in Healthy Chinese Participants
by: Congyang Ding, et al.
Published: (2026)

A Phase 1 Dose‐Escalation, Food Effect, and Drug–Drug Interaction Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MALT1 Inhibitor, SGR‐1505, in Healthy Volunteers
by: Vipul K. Gupta, et al.
Published: (2026)

Randomized Phase 1 Studies Evaluating the Safety, Tolerability, Pharmacokinetics, and Target Occupancy of Zampilimab in Healthy Participants
by: Jo Collier, et al.
Published: (2026)

Population Pharmacokinetics of Fasinumab in Healthy Volunteers and Patients With Pain Due to Osteoarthritis of the Knee or Hip
by: Kuan‐Ju Lin, et al.
Published: (2024)

LP‐001, a Novel Long‐Acting EPO‐Fc Fusion Protein: A Phase I Dose‐Escalation Study of Pharmacokinetics, Safety, and Tolerability in Healthy Chinese Subjects
by: Jie Yang, et al.
Published: (2026)

Pharmacokinetics, Bioequivalence, and Safety of Diclofenac Sodium Sustained‐Release Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions
by: Biao Sun, et al.
Published: (2026)

Safety, Tolerability, and Pharmacokinetics of the Long‐Acting SARS‐CoV‐2–Neutralizing Monoclonal Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) in Healthy Chinese Adults
by: Nanyang Li, et al.
Published: (2025)

Comparative Pharmacokinetics and Safety Assessment of 1st‐ and 2nd‐Generation Zinpentraxin Alfa Drug Products in Healthy Volunteers: A Randomized Crossover Study
by: Tu H. Mai, et al.
Published: (2024)

Pharmacokinetics and Safety of Linezolid Tablets of 2 Different Manufacturers in Healthy Chinese Subjects in Fasting and Fed States
by: Hanjing Chen, et al.
Published: (2024)

Pharmacokinetics and Bioequivalence of 2 Oral Formulations of Vildagliptin in Healthy Chinese Subjects
by: Mengli Tian, et al.
Published: (2024)

Comparison of the Pharmacokinetics of Three Budesonide Formulations in Healthy Chinese Subjects
by: Tengrui Yin, et al.
Published: (2025)

Bioequivalence Study of 2 Formulations of Fluticasone Nasal Spray in Healthy Chinese Volunteers
by: Gang Chen, et al.
Published: (2025)

Pharmacokinetics, Safety, and Tolerability of Single‐Dose Dazukibart in Healthy Adults in China and Japan: Results From 2 Randomized, Double‐Blind, Phase 1 Studies
by: Naihan Chen, et al.
Published: (2025)

A Randomized, Open‐Label, Two‐Sequence, Crossover Trial Evaluating the Bioequivalence, and Pharmacokinetics of Two Sulfamethoxazole/Trimethoprim Tablet Formulations in Healthy Chinese Volunteers Under Fasting Conditions
by: Xueqiong Peng, et al.
Published: (2025)

Correction to “Preclinical and Phase 1 Assessment of Antisense Oligonucleotide Bepirovirsenin Hepatitis B Virus–Transgenic Mice and Healthy Human Volunteers: Support for Clinical Dose Selection and Evaluation of Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses”
Published: (2025)

Pharmacokinetics and Bioequivalence of two Empagliflozin Tablet Formulations: Results From a Randomized, Open‐Label, Crossover Study in Fasting Healthy Volunteers
by: Kar Ming Yee, et al.
Published: (2025)